27,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
14 °P sammeln
  • Broschiertes Buch

The Short History of the Founding of the International Vaccine Institute According to the 25th Year Impact Report issued by IVI, the list of its accomplishments over the past quarter century was truly impressive. The report said that more than 3,000 vaccine professionals from all corners of the world received training through IVI's annual International Vaccinology Course. IVI was pivotal in the development of two major vaccines, an oral cholera vaccine and a typhoid conjugate vaccine, and was working on vaccines for 9 further infectious diseases. More than a million people have been vaccinated…mehr

Produktbeschreibung
The Short History of the Founding of the International Vaccine Institute According to the 25th Year Impact Report issued by IVI, the list of its accomplishments over the past quarter century was truly impressive. The report said that more than 3,000 vaccine professionals from all corners of the world received training through IVI's annual International Vaccinology Course. IVI was pivotal in the development of two major vaccines, an oral cholera vaccine and a typhoid conjugate vaccine, and was working on vaccines for 9 further infectious diseases. More than a million people have been vaccinated through IVI campaigns across Africa and Asia. This book tells the short history of the founding of the International Vaccine Institute by the United Nations Development Programme from 1992 to 1997; the beginning of the idea, drive and struggles of the people who made it possible, and the support of scientists from all over the world regardless of politics.
Autorenporträt
Seung-il ShinFormer Senior Health Advisor and Director of the IVI Project United Nations Development Programme Shin received undergraduate and graduate degrees from Brandeis University, and trained in human genetics at the University of Leiden. He was one of the founding members of the Basel Institute for Immunology in Switzerland. He then served as a Professor of Genetics at Albert Einstein College of Medicine in New York for 14 years, where his research was in somatic cell genetics and tumor biology. He was a co-founder and CEO of Eugene Tech International, a biotech venture based in New Jersey. He led the development and commercialization of a low-cost hepatitis B vaccine in a joint effort with the New York Blood Center, and played a leading role in an international campaign to bring the new vaccine to the developing world. The United Nations Development Programme in 1992 invited Shin to develop and implement a plan for an international center of vaccine sciences focused on the needs of developing countries under the aegis of the Children's Vaccine Initiative, a global movement to expand the availability of affordable vaccines for the world's children. The UNDP-initiative eventually led to the birth of the International Vaccine Institute (IVI) in 1997. In this memoir, Shin recounts how, despite some initial difficulties, international partners came together to create IVI and to find a home for it in Seoul, Korea.